Catalent | CTLT - Market Capitalization


Catalent reported $11.48B in Market Capitalization this December of 2024, considering the latest stock price and the number of outstanding shares.



Market Capitalization Change Date
Agilent USD 41.49B 8.93B Sep/2025
AstraZeneca USD 222.33B 65.82B Feb/2026
Bristol-Myers Squibb USD 123.58B 13.77B Feb/2026
Bruker USD 5.69B 1.47B Feb/2026
Centene USD 19.14B 1.08B Feb/2026
Charles River Laboratories USD 7.31B 57M Sep/2025
Cigna USD 80.66B 7.14B Feb/2026
Danaher USD 161.7B 29.34B Dec/2025
Dentsply International USD 2.53B 633M Sep/2025
Elevance Health USD 77.91B 5.15B Dec/2025
Eli Lilly USD 1.01T 3.37B Feb/2026
Glaxosmithkline GBP 106.96B 20.08B Feb/2026
Hologic USD 16.62B 1.67B Dec/2025
Humana USD 21.14B 9.66B Feb/2026
Illumina USD 21.21B 588M Feb/2026
Intuitive Surgical USD 200.77B 40.45B Dec/2025
IQVIA Holdings USD 32.84B 5.54B Feb/2026
J&J USD 500.24B 67.44B Dec/2025
Laboratory Of America USD 23.83B 1.85B Sep/2025
Lonza CHF 39.68B 980.61M Jun/2025
McKesson USD 108.02B 6.77B Feb/2026
Merck EUR 47.59B 239.13M Sep/2025
Merck USD 300.37B 39.11B Feb/2026
Mettler Toledo International USD 29.7B 1.22B Feb/2026
Novartis USD 265.66B 9.48B Sep/2025
Pfizer USD 152.89B 11.32B Feb/2026
Quest Diagnostics USD 22.92B 3.62B Feb/2026
Repligen USD 7.52B 532M Sep/2025
Revvity USD 12.58B 1.61B Feb/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Supernus Pharmaceuticals USD 3B 1.24B Sep/2025
Thermo Fisher Scientific USD 217.7B 42.4B Dec/2025
UnitedHealth USD 265.18B 33.84B Feb/2026
Waters USD 19.43B 3.19B Feb/2026
West Pharmaceutical Services USD 17.83B 1.96B Feb/2026